Previous close | 251.49 |
Open | 253.53 |
Bid | 257.74 x 900 |
Ask | 409.29 x 800 |
Day's range | 250.37 - 258.13 |
52-week range | 244.81 - 428.36 |
Volume | |
Avg. volume | 359,961 |
Market cap | 12.103B |
Beta (5Y monthly) | 1.13 |
PE ratio (TTM) | 25.10 |
EPS (TTM) | 10.28 |
Earnings date | 27 July 2022 - 01 Aug 2022 |
Forward dividend & yield | 1.36 (0.55%) |
Ex-dividend date | 13 May 2022 |
1y target est | 352.80 |
Today we will run through one way of estimating the intrinsic value of Teleflex Incorporated ( NYSE:TFX ) by taking the...
Study Intends to Demonstrate that Ultrasound Allows for Precise Deployment and Positive Positioning of the MANTA® Vascular Closure DeviceWAYNE, Pa., June 22, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study that is intended to demonstrate the safety of MANTA® Vascular Closure Device ultrasound (U/S) guided closure, without dependence on the pre-procedural depth locator m
Investors are optimistic about Teleflex's (TFX) better-than-expected results and strong growth within the vascular business.